Bio-Techne Corporation is a publicly traded company, listed on the Nasdaq stock exchange under the ticker symbol TECH. As a major player in the biotechnology and life sciences tools industry, it is owned by a diverse base of institutional and individual shareholders. Its status as a public entity means it must adhere to rigorous financial reporting standards, file quarterly and annual reports with the Securities and Exchange Commission, and maintain transparent governance practices overseen by a Board of Directors. Investors can buy and sell shares of Bio-Techne on the public markets during active trading hours, and the company’s corporate strategy and fiscal performance are subjected to regular scrutiny by equity analysts and the broader investment community. This structure allows the company to raise significant capital from the public markets to fuel its research, development, and strategic acquisition efforts across the global life sciences sector.
Biotechnology is broadly categorized into four primary sectors, represented by different colors: Red, Green, White, and Blue.
The biotechnology sector is well-known for offering highly competitive compensation packages, especially for roles that require specialized technical education, such as Ph.D. holders, molecular biologists, data scientists, and process engineers.
No, biotech jobs are not broadly declining; in fact, the sector has demonstrated remarkable resilience and long-term secular growth driven by advances in medicine, aging global demographics, and the digital transformation of biological research.
Bio-Techne provides an extensive and highly sophisticated catalog of research products that serve as foundational tools for life science laboratories worldwide.
Bio-Techne Corporation reports significant annual revenues reflecting its position as a global leader in life sciences tools and clinical diagnostics.
A career in biotechnology can be demanding and, at times, inherently stressful due to the high-stakes environment in which professionals operate.
Determining the "best" biotechnology course depends heavily on your professional goals—whether you aim for research, manufacturing, regulatory affairs, or computational biology.
Bio-Techne’s company values are centered on driving scientific discovery through innovation, integrity, and customer-centricity.
Bio-Techne Corporation is a premier manufacturer of high-quality life science research tools, reagents, and clinical diagnostic products.
Biotechnology is generally considered a high-paying field, particularly when compared to average national salary benchmarks in many developed nations.
Bio-Techne is generally perceived as a strong, stable employer within the life sciences sector, known for offering a professional work environment, competitive compensation, and a clear alignment with the mission of advancing scientific discovery.
Bio-Techne operates in a highly competitive life sciences tools and clinical diagnostics market, facing rivalry from other global giants that also manufacture research reagents, proteins, and analytical instrumentation.
Biotechnology carries significant risks that require careful ethical and regulatory oversight.
Bio-Techne Corporation, originally founded as Techne Corporation in 1976, has a history rooted in the evolution of modern molecular biology and the demand for high-quality research tools.
Biotechnology and genetic engineering are closely related but represent different concepts in the scientific field.
Bio-Techne Corporation employs several thousand highly skilled professionals across its global operations, which include manufacturing sites, research facilities, and commercial sales offices.
Determining whether Bio-Techne (TECH) stock is a "good buy" depends entirely on your personal investment philosophy, your risk tolerance, and your analysis of the life sciences market.
The timeline to become a professional in the biotechnology field varies by the specific role.
Bio-Techne Corporation is headquartered in Minneapolis, Minnesota, in the United States. This central location serves as the hub for the company’s executive leadership, strategic operations, and financial administration.
Bio-Techne Corporation functions as a vital supplier and technology partner to the global life sciences and pharmaceutical research communities.
Salaries in the biotechnology field are highly variable and depend on factors such as educational level, specific job function, geographic location, and company size.
Yes, Bio-Techne Corporation is a large, significant player in the global life sciences industry.
The amount of math in biotechnology varies significantly depending on your role.
Kim Kelderman serves as the Chief Executive Officer of Bio-Techne Corporation. Taking on this leadership role, he is responsible for overseeing the company's long-term strategic vision, global operations, and financial performance.
Comparing the difficulty of biotechnology and engineering is inherently subjective, as both fields are intellectually demanding but require different types of cognitive approaches.